The efficacy of immune checkpoint inhibitors following discontinuation for long‐term response or toxicity in advanced or metastatic non‐small‐cell lung cancers: A retrospective study

Autor: Laure Vacher, Maureen Bernadach, Ioana Molnar, Judith Passildas‐Jahanmohan, Pascale Dubray‐Longeras

Publikováno v: Health Science Reports, Vol 7, Iss 1, Pp n/a-n/a (2024)

Abstract Background and Aims The treatment of metastatic non‐small‐cell lung cancer (NSCLC) has been revolutionized by the arrival of immune checkpoint inhibitors (ICI). For patients without immune related adverse events (irAEs), it is recommende

Externí odkaz: https://doaj.org/article/98757861f86e4525868fd9e12b5ef347

Improvement in adherence to Capecitabine and Lapatinib by way of a therapeutic education program

Autor: Philippe Chollet, Xavier Durando, Isabelle Van Praagh-Doreau, Marie-Ange Mouret-Reynier, Fabrice Kwiatkowski, Hervé Devaud, Régine Chevrier, Emilie Thivat, Pascale Dubray-Longeras, Camille Poirier, Laure Vacher

Publikováno v: Supportive Care in Cancer
Supportive Care in Cancer, 2020, 28 (7), pp.3313-3322. ⟨10.1007/s00520-019-05144-x⟩
Supportive Care in Cancer, Springer Verlag (Germany), 2020, 28 (7), pp.3313-3322. ⟨10.1007/s00520-019-05144-x⟩

A patient non-adherence with oral anticancer agents is a well-recognized barrier to effective treatment. The aim of this prospective study was to evaluate the efficacy of a therapeutic education program among non-adherent patients treated with Capeci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c445be8c371154d24c21dcf5f7df95b
https://doi.org/10.1007/s00520-019-05144-x